vs
BALCHEM CORP（BCPC）与Zurn Elkay Water Solutions Corp（ZWS）财务数据对比。点击上方公司名可切换其他公司
Zurn Elkay Water Solutions Corp的季度营收约是BALCHEM CORP的1.5倍（$407.2M vs $263.6M），BALCHEM CORP净利率更高（14.9% vs 10.3%，领先4.5%），Zurn Elkay Water Solutions Corp同比增速更快（9.8% vs 9.8%），过去两年BALCHEM CORP的营收复合增速更高（4.9% vs 4.4%）
Balchem Corp是一家全球特种化学品与营养原料供应商，核心业务覆盖人类营养、动物保健、制药、工业应用四大领域，为北美、欧洲、亚太等地区的客户提供定制化专用原料产品。
Zurn Elkay Water Solutions是一家专业水资源管理解决方案提供商，主要生产销售商用给排水设备、饮用水系统、过滤产品及流量控制组件，服务北美及全球的商用、住宅、工业和公共基建领域，主打高效节水的可持续产品。
BCPC vs ZWS — 直观对比
营收规模更大
ZWS
是对方的1.5倍
$263.6M
营收增速更快
ZWS
高出0.0%
9.8%
净利率更高
BCPC
高出4.5%
10.3%
两年增速更快
BCPC
近两年复合增速
4.4%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $263.6M | $407.2M |
| 净利润 | $39.2M | $42.1M |
| 毛利率 | 35.6% | 44.4% |
| 营业利润率 | 19.8% | 14.8% |
| 净利率 | 14.9% | 10.3% |
| 营收同比 | 9.8% | 9.8% |
| 净利润同比 | 16.8% | 15.7% |
| 每股收益（稀释后） | $1.21 | $0.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BCPCZWS
| Q4 25 | $263.6M | $407.2M | ||
| Q3 25 | $267.6M | $455.4M | ||
| Q2 25 | $255.5M | $444.5M | ||
| Q1 25 | $250.5M | $388.8M | ||
| Q4 24 | $240.0M | $370.7M | ||
| Q3 24 | $239.9M | $410.0M | ||
| Q2 24 | $234.1M | $412.0M | ||
| Q1 24 | $239.7M | $373.8M |
净利润BCPCZWS
| Q4 25 | $39.2M | $42.1M | ||
| Q3 25 | $40.3M | $61.8M | ||
| Q2 25 | $38.3M | $50.5M | ||
| Q1 25 | $37.1M | $43.6M | ||
| Q4 24 | $33.6M | $36.4M | ||
| Q3 24 | $33.8M | $43.5M | ||
| Q2 24 | $32.1M | $46.0M | ||
| Q1 24 | $29.0M | $34.3M |
毛利率BCPCZWS
| Q4 25 | 35.6% | 44.4% | ||
| Q3 25 | 35.7% | 44.1% | ||
| Q2 25 | 36.4% | 45.5% | ||
| Q1 25 | 35.2% | 46.6% | ||
| Q4 24 | 36.0% | 43.5% | ||
| Q3 24 | 35.6% | 46.2% | ||
| Q2 24 | 35.5% | 45.2% | ||
| Q1 24 | 34.0% | 45.5% |
营业利润率BCPCZWS
| Q4 25 | 19.8% | 14.8% | ||
| Q3 25 | 20.4% | 17.0% | ||
| Q2 25 | 20.1% | 17.5% | ||
| Q1 25 | 20.4% | 16.3% | ||
| Q4 24 | 19.8% | 13.3% | ||
| Q3 24 | 20.0% | 17.1% | ||
| Q2 24 | 19.6% | 17.5% | ||
| Q1 24 | 17.4% | 14.2% |
净利率BCPCZWS
| Q4 25 | 14.9% | 10.3% | ||
| Q3 25 | 15.1% | 13.6% | ||
| Q2 25 | 15.0% | 11.4% | ||
| Q1 25 | 14.8% | 11.2% | ||
| Q4 24 | 14.0% | 9.8% | ||
| Q3 24 | 14.1% | 10.6% | ||
| Q2 24 | 13.7% | 11.2% | ||
| Q1 24 | 12.1% | 9.2% |
每股收益（稀释后）BCPCZWS
| Q4 25 | $1.21 | $0.24 | ||
| Q3 25 | $1.24 | $0.36 | ||
| Q2 25 | $1.17 | $0.29 | ||
| Q1 25 | $1.13 | $0.26 | ||
| Q4 24 | $1.03 | $0.21 | ||
| Q3 24 | $1.03 | $0.25 | ||
| Q2 24 | $0.98 | $0.27 | ||
| Q1 24 | $0.89 | $0.19 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $74.6M | $300.5M |
| 总债务越低越好 | — | $496.5M |
| 股东权益账面价值 | $1.3B | $1.6B |
| 总资产 | $1.7B | $2.7B |
| 负债/权益比越低杠杆越低 | — | 0.31× |
8季度趋势，按日历期对齐
现金及短期投资BCPCZWS
| Q4 25 | $74.6M | $300.5M | ||
| Q3 25 | $65.1M | $260.1M | ||
| Q2 25 | $65.4M | $201.9M | ||
| Q1 25 | $49.9M | $144.7M | ||
| Q4 24 | $49.5M | $198.0M | ||
| Q3 24 | $73.7M | $187.9M | ||
| Q2 24 | $63.7M | $162.7M | ||
| Q1 24 | $60.3M | $157.1M |
总债务BCPCZWS
| Q4 25 | — | $496.5M | ||
| Q3 25 | — | $496.4M | ||
| Q2 25 | — | $495.9M | ||
| Q1 25 | — | $495.8M | ||
| Q4 24 | — | $495.6M | ||
| Q3 24 | — | $495.6M | ||
| Q2 24 | — | $495.5M | ||
| Q1 24 | — | $495.4M |
股东权益BCPCZWS
| Q4 25 | $1.3B | $1.6B | ||
| Q3 25 | $1.3B | $1.6B | ||
| Q2 25 | $1.3B | $1.6B | ||
| Q1 25 | $1.2B | $1.5B | ||
| Q4 24 | $1.1B | $1.6B | ||
| Q3 24 | $1.2B | $1.6B | ||
| Q2 24 | $1.1B | $1.6B | ||
| Q1 24 | $1.1B | $1.6B |
总资产BCPCZWS
| Q4 25 | $1.7B | $2.7B | ||
| Q3 25 | $1.7B | $2.7B | ||
| Q2 25 | $1.7B | $2.7B | ||
| Q1 25 | $1.6B | $2.6B | ||
| Q4 24 | $1.6B | $2.6B | ||
| Q3 24 | $1.6B | $2.7B | ||
| Q2 24 | $1.6B | $2.7B | ||
| Q1 24 | $1.6B | $2.7B |
负债/权益比BCPCZWS
| Q4 25 | — | 0.31× | ||
| Q3 25 | — | 0.31× | ||
| Q2 25 | — | 0.32× | ||
| Q1 25 | — | 0.32× | ||
| Q4 24 | — | 0.31× | ||
| Q3 24 | — | 0.31× | ||
| Q2 24 | — | 0.31× | ||
| Q1 24 | — | 0.31× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $67.3M | $91.7M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | 1.72× | 2.18× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流BCPCZWS
| Q4 25 | $67.3M | $91.7M | ||
| Q3 25 | $65.6M | $101.3M | ||
| Q2 25 | $47.3M | $110.6M | ||
| Q1 25 | $36.5M | $42.9M | ||
| Q4 24 | $52.3M | $63.6M | ||
| Q3 24 | $51.3M | $90.9M | ||
| Q2 24 | $45.0M | $85.1M | ||
| Q1 24 | $33.4M | $53.9M |
现金转化率BCPCZWS
| Q4 25 | 1.72× | 2.18× | ||
| Q3 25 | 1.63× | 1.64× | ||
| Q2 25 | 1.23× | 2.19× | ||
| Q1 25 | 0.98× | 0.98× | ||
| Q4 24 | 1.56× | 1.75× | ||
| Q3 24 | 1.52× | 2.09× | ||
| Q2 24 | 1.40× | 1.85× | ||
| Q1 24 | 1.15× | 1.57× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
BCPC
| Human Nutrition And Health | $166.1M | 63% |
| Animal Nutrition And Health | $61.2M | 23% |
| Specialty Products | $34.8M | 13% |
ZWS
暂无分部数据
